Cardiovascular disease mortality in Hispanics and non-Hispanic whites

Carolyn J Swenson1, Mary Jo Trepka, Marian J Rewers

  • 1Department of Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, CO 80262, USA.

Insights

Hispanics, particularly those with diabetes, showed lower cardiovascular disease (CVD) mortality than non-Hispanic Whites. This suggests underlying factors may protect Hispanic populations from CVD death despite risk profiles.

Area of Science:

  • Epidemiology
  • Cardiovascular Health
  • Diabetes Research

Background:

  • Hispanic populations often exhibit a worse cardiovascular disease (CVD) risk profile compared to non-Hispanic Whites.
  • Previous studies using death certificates indicated lower CVD mortality rates among Hispanics.

Purpose of the Study:

  • To investigate the discrepancy in CVD mortality between Hispanic and non-Hispanic White individuals.
  • To examine cause-specific mortality using medical records for a more accurate assessment.

Main Methods:

  • Analysis of 310 deaths from 1984-1998 within the San Luis Valley Diabetes Study (1,862 participants).
  • Medical records were used to classify the cause of death, differentiating between individuals with and without diabetes.
  • Hazard ratios were calculated to compare CVD and coronary heart disease mortality between ethnic groups.

Main Results:

  • Among individuals with diabetes, Hispanic participants had significantly lower age-adjusted CVD mortality (8.8/1,000 person-years) compared to non-Hispanic Whites (12.9/1,000 person-years).
  • The adjusted hazard ratio for CVD death in diabetic Hispanics versus non-Hispanic Whites was 0.44 (95% CI: 0.26, 0.74).
  • A statistically significant decreased risk of CVD death was observed specifically in male Hispanics with diabetes.

Conclusions:

  • The study confirms a lower CVD mortality in Hispanics, especially those with diabetes, contradicting their risk profiles.
  • Factors interacting with diabetes or competing causes of mortality may explain these observed ethnic differences in CVD outcomes.

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...